| Serial Number | 79363427 |
| Word Mark | ARCHIVECT |
| Filing Date | Wednesday, January 11, 2023 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, April 9, 2024 |
| Registration Number | 7349628 |
| Registration Date | Tuesday, April 9, 2024 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 23, 2024 |
| Goods and Services | Viral systems comprised of viral vectors combined with antibodies; gene therapy systems comprised of viral vectors combined with antibodies; nucleic acid delivery systems being therapeutic agents for delivery to human tissue namely viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes; pharmaceutical products for the treatment of neuro degenerative and neuromuscular disorders being autoimmune diseases; biological preparations for the treatment neuro degenerative and neuromuscular disorders being autoimmune diseases; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy for the treatment of neuro degenerative and neuromuscular disorders being autoimmune diseases; clinical medical reagents for use in nucleic acid-based therapy, cell therapy, pharmaceutical preparations, prophylaxis products preparations and other pharmaceutical products preparations and other pharmaceutical products preparations for use in nucleic acid-based therapy, gene therapy for the treatment of neuro degenerative and neuromuscular disorders being autoimmune diseases |
| Goods and Services | Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; consultancy in the field of pharmaceutics |
| Goods and Services | Scientific and medical research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; Scientific and medical research and product development in the field of pharmaceutics |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 052, 051, 005, 018, 006, 044, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 24, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 24, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 24, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | VectorY B.V. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 26 - NOT AVAILABLE |
| Address | NL |
| Party Name | VectorY B.V. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 26 - NOT AVAILABLE |
| Address | NL |
| Party Name | VectorY B.V. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 26 - NOT AVAILABLE |
| Address | NL |
| Event Date | Event Description |
| Tuesday, April 9, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, April 9, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, January 23, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 23, 2024 | PUBLISHED FOR OPPOSITION |
| Monday, January 22, 2024 | NOTIFICATION PROCESSED BY IB |
| Wednesday, January 3, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, January 3, 2024 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, January 3, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, December 18, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, December 12, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, December 12, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, December 12, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, December 12, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, December 8, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 7, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, December 7, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, July 26, 2023 | REFUSAL PROCESSED BY IB |
| Saturday, July 1, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, July 1, 2023 | REFUSAL PROCESSED BY MPU |
| Saturday, May 20, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, May 19, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, May 18, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, February 28, 2023 | APPLICATION FILING RECEIPT MAILED |
| Friday, February 24, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, February 23, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |